Skip to content

Hepatitis C infection limits cholesterol increases caused by antiretrovirals

Darunavir response did not differ by prior PI in POWER studies

Reduced dose of Kaletra soft-gel capsule effective in small study (corrected)

Immunologically discordant response to HIV therapy associated with increased risk of disease progression

Needle-free administration of enfuvirtide reduces injection site reactions

Community-acquired MRSA soars among people with HIV in San Francisco

Kaletra, saquinavir have anti-malarial effects in test tube

EU survey finds widespread ignorance of HIV transmission risks

Higher baseline HCV viral load and CD4 percentage predict response to hepatitis C treatment in HIV/HCV co-infected patients